High prevalence of hepatitis B virus infection among tuberculosis patients with and without HIV in Rio de Janeiro, Brazil

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 24, Issue 1, 2005, Pages 41-43

  Blal, C A ^a   Passos, S R L ^a   Horn, C ^a   Georg, I ^a   Bonecini Almeida, M G ^a   Rolla, V C ^a   De Castro, L ^a  

^a Ctro Pesquisa Hosp Evandro C   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAZIL; CONTROLLED STUDY; HEPATITIS B; HEPATITIS B VIRUS; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; SEROPREVALENCE; TUBERCULOSIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BRAZIL; CASE-CONTROL STUDIES; COMORBIDITY; FEMALE; HEPATITIS B; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEROLOGIC TESTS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL RATE; TUBERCULOSIS, PULMONARY; URBAN POPULATION;

EID: 13144281745     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-004-1272-8     Document Type: Article

References (15)

1. Madrey WC (2000) Hepatitis B - an important public health issue. J Med Virol 61:362-366
2. Puoti M, Airoldi M, Bruno R, Zanini B, Spinetti A, Pezzoli C, Patron A, Castelli F, Sacchi P, Fillice G, Carosi G (2002) Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects. AIDS Rev 4:27-35
3. Brinker M, Ferdinand WN, Pauline ME, Dillen W, Juriaans S, Well J, Leeuwen R, Pakker N, Reiss P, Danner S, Weverling G, Lang J (2000) Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection. AIDS 14:2895-2902
4. Patel PA, Voigt MD (2002) Prevalence and interaction of hepatitis B and latent tuberculosis in Vietnamese immigrants to the United States. Am J Gastroenterol 97:1198-1203
5. Aceti A, Pasquazzi C, Zechini B, Bac C (2002) Hepatotoxicity development during retroviral therapy containing protease inhibitors in patients with HIV. J AIDS 29:41-48
6. Wong WN, Wu PC, Yuen MF, Cheng CC, Yew WW, Wong PC, Tam CM, Leung CC, Lai CL (2000) Antituberculosis drug-related liver disfunction in chronic hepatitis B infection. Hepatology 31:201-206
7. Santos EA, Yoshida FT, Rolla VC, Mendes JM, Vieira IF, Arabe J, Gomes SA (2003) Frequent occult hepatitis B virus infection in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 22:92-98
8. Piroth L, Binquet C, Vergne M, Minello A, Livry C, Bour JB, Buisson M, Duong M, Grappin M, Portier H, Chavanet P (2002) The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients. J Hepatol 36:681-686
9. Tanaka J (2000) Hepatitis B epidemiology in Latin America. Vaccine 18:17-19
10. Martelli CMT, Turchi MD, Souto FJD, Saez-Alquezar A, Andrade ALS, Zicker F (1999) Anti-HBc testing for blood donations in areas with intermediate hepatitis B endemicity. Rev Panam Salud Publica 6:69-73
11. Damme PV, Cramm M, Auwera JC, Vranckx R, Meheus A (1995) Horizontal transmission of hepatitis B virus. Lancet 345:27-29
12. Fisher N, Georgsen J, Stolborg T, Khalil MR, Christensen PB (2002) Low hepatitis B prevalence among pre-school children in Denmark: saliva anti-HBc screening in day care centers. J Med Virol 68:500-504
13. Van der Eijk AA, Niesters HG, Gotz HM, Janssen HL, Schalm SW, Osterhaus AD, de Man RA (2004) Paired measurements of quantitative hepatitis B virus DNA in saliva and serum of chronic hepatitis B patients: implications for saliva as infectious agent. J Clin Virol 29:92-94
14. Cantwell MF, McKenna MT, McCray E, Onorato IM (1998) Tuberculosis and race/ethnicity in the United States. Am J Respir Crit Care Med 157:1016-1020
15. Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD (2002) Hepatotoxicity associated with nevirapine or efavirenz containing antiretroviral therapy: role of hepatitis C and B infections. Hepatology 35:182-189